Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancers|July 9, 2020
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell CarcinomasDaniel Pedregal-Mallo, Francisco Hermida-Prado, Rocío Granda-Díaz, et al.
Cancers|January 26, 2021
Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer MicroenvironmentFaustino Julián Suárez-Sánchez, Paloma Lequerica-Fernández, Juan Pablo Rodrigo, et al.
Cancers|July 24, 2019
Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of MelatoninJavier Menéndez-Menéndez, Francisco Hermida-Prado, Rocío Granda-Díaz, et al.
Scientific Reports|October 27, 2015
Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomasJuan P Rodrigo, Sofía Tirados Menéndez, Francisco Hermida-Prado, et al.
Biomedicines|December 1, 2020
Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell CarcinomaMario Sanchez-Canteli, Francisco Hermida-Prado, Christian Sordo-Bahamonde, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 12, 2019
MAPK inhibition and growth hormone: a promising therapy in XLHRocío Fuente, Helena Gil-Peña, Débora Claramunt-Taberner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomicsLlara Prieto-Fernandez, Maria de Los Angeles Villaronga, Francisco Hermida-Prado, et al.
Cancers|November 17, 2019
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell CarcinomaFrancisco Hermida-Prado, Rocío Granda-Díaz, Nagore Del-Río-Ibisate, et al.
Cancers|March 3, 2019
The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous LesionsRocío Granda-Díaz, Sofía T Menéndez, Daniel Pedregal Mallo, et al.
JCI Insight|May 6, 2025
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor-positive breast cancerShira Sherman, Zachary M Sandusky, Douglas Russo, et al.
Pageof 4